RBC Capital Maintains Outperform on Johnson & Johnson, Lowers Price Target to $175
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Shagun Singh maintains an Outperform rating on Johnson & Johnson (JNJ) but lowers the price target from $181 to $175.

April 17, 2024 | 5:11 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
RBC Capital maintains an Outperform rating on Johnson & Johnson but lowers the price target from $181 to $175.
The adjustment in price target by RBC Capital, while maintaining an Outperform rating, suggests a continued positive outlook on JNJ but with a slightly moderated growth expectation. This could lead to a neutral short-term impact on JNJ's stock price as the market digests the new price target against the backdrop of ongoing bullish sentiment.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100